ZA200609136B - 4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide - Google Patents

4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide

Info

Publication number: ZA200609136B
Authority: ZA; South Africa
Prior art keywords: benzothiazol; morpholin; piperidine; methoxy; amide
Prior art date: 2004-05-24

Application number

ZA200609136A

Other languages

English (en)

Inventor

Flohr Alexander

Poli Sonia Maria

Steward Lucinda

Moreau Jean-Luc

Riemer Claus

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-24

Filing date

2006-11-02

Publication date

2008-07-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200609136(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-11-02 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2008-07-30 Publication of ZA200609136B publication Critical patent/ZA200609136B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA200609136A 2004-05-24 2006-11-02 4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide ZA200609136B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04102262		2004-05-24

Publications (1)

Publication Number	Publication Date
ZA200609136B true ZA200609136B (en)	2008-07-30

Family

ID=34967309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200609136A ZA200609136B (en)	2004-05-24	2006-11-02	4-Hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide

Country Status (38)

Country	Link
US (1)	US7368446B2 (xx)
EP (1)	EP1753760B1 (xx)
JP (1)	JP4668265B2 (xx)
CN (1)	CN1956983B (xx)
AR (1)	AR048973A1 (xx)
AT (1)	ATE382619T1 (xx)
AU (1)	AU2005247567B2 (xx)
BR (1)	BRPI0511543B1 (xx)
CA (1)	CA2567703C (xx)
CR (1)	CR8703A (xx)
CY (1)	CY1108104T1 (xx)
DE (1)	DE602005004142T2 (xx)
DK (1)	DK1753760T3 (xx)
DO (1)	DOP2005000091A (xx)
EA (1)	EA011279B1 (xx)
EC (1)	ECSP067018A (xx)
ES (1)	ES2297710T3 (xx)
GT (1)	GT200500124A (xx)
HN (1)	HN2005000238A (xx)
HR (1)	HRP20080027T3 (xx)
IL (1)	IL179364A (xx)
MA (1)	MA28601B1 (xx)
MX (1)	MXPA06013417A (xx)
MY (1)	MY140011A (xx)
NO (1)	NO336939B1 (xx)
NZ (1)	NZ550763A (xx)
PA (1)	PA8633901A1 (xx)
PE (1)	PE20060274A1 (xx)
PL (1)	PL1753760T3 (xx)
PT (1)	PT1753760E (xx)
RS (1)	RS50574B (xx)
SI (1)	SI1753760T1 (xx)
SV (1)	SV2006002125A (xx)
TN (1)	TNSN06371A1 (xx)
TW (1)	TWI358297B (xx)
UA (1)	UA87142C2 (xx)
WO (1)	WO2005116026A1 (xx)
ZA (1)	ZA200609136B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE521512C2 (sv) *	2001-06-25	2003-11-11	Niconovum Ab	Anordning för administrering av en substans till främre delen av en individs munhåla
ES2708552T3 (es) *	2002-12-20	2019-04-10	Niconovum Ab	Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
JP5694645B2 (ja)	2006-03-16	2015-04-01	ニコノヴァムエービーＮｉｃｏｎｏｖｕｍＡｂ	改善された嗅ぎたばこ組成物
CN101873799A (zh) *	2007-07-23	2010-10-27	辛诺西亚治疗公司	用于治疗创伤后应激障碍的4-羟基-4-甲基-哌啶-1-羧酸(4-甲氧基-7-吗啉-4-基-苯并噻唑-2-基)-酰胺
EA020460B1 (ru)	2009-01-12	2014-11-28	Пфайзер Лимитед	Производные сульфонамида
US8168785B2 (en) *	2009-06-17	2012-05-01	Biotie Therapies, Inc.	Benzothiazole derivatives
WO2011101861A1 (en)	2010-01-29	2011-08-25	Msn Laboratories Limited	Process for preparation of dpp-iv inhibitors
EP2590972B1 (en)	2010-07-09	2015-01-21	Pfizer Limited	N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels
WO2012060844A1 (en) *	2010-11-05	2012-05-10	Biotie Therapies, Inc	A2a antagonists as cognition and motor function enhancers
ES2627541T3 (es) *	2012-04-20	2017-07-28	Ucb Pharma, S.A.	Métodos para tratar la enfermedad de Parkinson
HK1252549A1 (zh) *	2015-06-19	2019-05-31	Biotie Therapies, Inc.	控释tozadenant制剂
WO2018059531A1 (zh) *	2016-09-30	2018-04-05	苏州晶云药物科技有限公司	一种腺苷a2a受体拮抗剂药物的晶型及其制备方法和用途
CA3073343A1 (en)	2017-08-21	2019-02-28	Merck Patent Gmbh	Quinoxaline derivatives as adenosine receptor antagonists
JP7287952B2 (ja) *	2017-08-21	2023-06-06	メルクパテントゲゼルシャフトミットベシュレンクテルハフツング	アデノシン受容体アンタゴニストとしてのベンズイミダゾール誘導体
WO2019141096A1 (zh) *	2018-01-19	2019-07-25	四川科伦博泰生物医药股份有限公司	取代脲类化合物及其制备方法和用途
JP2022515741A (ja)	2018-12-20	2022-02-22	バイオティーセラピーズインコーポレイテッド	トザデナントを使用して癌を処置する方法
DE102019110904B4 (de)	2019-04-26	2022-01-20	Helmholtz-Zentrum Dresden - Rossendorf E. V.	N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung
CN116407539B (zh) *	2021-12-30	2025-01-10	上海现代药物制剂工程研究中心有限公司	依匹哌唑甲基脂肪酸酯的用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH505543A (de)	1968-11-01	1971-04-15	Ciba Geigy Ag	Schädlingsbekämpfungsmittel
LU63457A1 (xx)	1970-07-06	1971-11-12
US4028374A (en) *	1975-11-03	1977-06-07	Morton-Norwich Products, Inc.	Antibacterial thiocyanatobenzothiazoles
DE2656468A1 (de)	1976-12-14	1978-06-15	Boehringer Mannheim Gmbh	N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung
KR930005004B1 (ko)	1985-04-15	1993-06-11	쟈안센 파아마슈우티카 엔. 부이.	치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FI91859C (fi)	1987-06-17	1994-08-25	Eisai Co Ltd	Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
IL90337A0 (en)	1988-05-24	1989-12-15	Pfizer	Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
WO1990015801A1 (en)	1989-06-22	1990-12-27	Pfizer Inc.	Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
DK0427963T3 (da)	1989-11-10	1994-05-02	Agrolinz Agrarchemikalien	Fremgangsmåde til fremstilling af rene, asymmetrisk disubstituerede urinstoffer
JP2759228B2 (ja)	1992-05-21	1998-05-28	株式会社大塚製薬工場	ホスホン酸ジエステル誘導体
FR2753970B1 (fr)	1996-10-01	1998-10-30	Synthelabo	Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
JPH11130761A (ja)	1997-10-24	1999-05-18	Otsuka Pharmaceut Co Ltd	ベンゾチアゾール誘導体
RU2212407C2 (ru)	1997-11-10	2003-09-20	Бристол-Маерс Сквибб Компани	Бензотиазольные ингибиторы протеинтирозинкиназ
CA2318969A1 (en)	1998-01-23	1999-07-29	Mikhail F. Gordeev	Oxazolidinone combinatorial libraries, compositions and methods of preparation
WO2000018767A2 (en)	1998-09-30	2000-04-06	Neurogen Corporation	2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
UA71587C2 (uk)	1998-11-10	2004-12-15	Шерінг Акцієнгезелльшафт	Аміди антранілової кислоти та їхнє застосування як лікарських засобів
GB9824579D0 (en) *	1998-11-10	1999-01-06	Novartis Ag	Organic compounds
IL133680A0 (en)	1999-09-10	2001-04-30	Can Fite Technologies Ltd	Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
WO2001087786A1 (en)	2000-05-12	2001-11-22	Corning Incorporated	Method for manufacturing an optical fiber preform with a protective coating
KR100526487B1 (ko) *	2000-06-21	2005-11-08	에프. 호프만-라 로슈 아게	벤조티아졸 유도체
US6727247B2 (en) *	2001-12-10	2004-04-27	Hoffman-La Roche Inc.	Substituted benzothiazole amide derivatives
US6713499B2 (en) *	2001-12-12	2004-03-30	Hoffman-La Roche Inc.	7-Amino-benzothiazole derivatives

2005
- 2005-05-17 WO PCT/EP2005/005329 patent/WO2005116026A1/en not_active Ceased
- 2005-05-17 HR HR20080027T patent/HRP20080027T3/xx unknown
- 2005-05-17 AT AT05741185T patent/ATE382619T1/de active
- 2005-05-17 CN CN200580016875XA patent/CN1956983B/zh not_active Expired - Fee Related
- 2005-05-17 AU AU2005247567A patent/AU2005247567B2/en not_active Expired
- 2005-05-17 BR BRPI0511543-4A patent/BRPI0511543B1/pt not_active IP Right Cessation
- 2005-05-17 ES ES05741185T patent/ES2297710T3/es not_active Expired - Lifetime
- 2005-05-17 SI SI200530160T patent/SI1753760T1/sl unknown
- 2005-05-17 UA UAA200613530A patent/UA87142C2/ru unknown
- 2005-05-17 PL PL05741185T patent/PL1753760T3/pl unknown
- 2005-05-17 EA EA200602048A patent/EA011279B1/ru not_active IP Right Cessation
- 2005-05-17 CA CA2567703A patent/CA2567703C/en not_active Expired - Lifetime
- 2005-05-17 RS RSP-2008/0125A patent/RS50574B/sr unknown
- 2005-05-17 EP EP05741185A patent/EP1753760B1/en not_active Expired - Lifetime
- 2005-05-17 DK DK05741185T patent/DK1753760T3/da active
- 2005-05-17 NZ NZ550763A patent/NZ550763A/en not_active IP Right Cessation
- 2005-05-17 PT PT05741185T patent/PT1753760E/pt unknown
- 2005-05-17 DE DE602005004142T patent/DE602005004142T2/de not_active Expired - Lifetime
- 2005-05-17 MX MXPA06013417A patent/MXPA06013417A/es active IP Right Grant
- 2005-05-17 JP JP2007513750A patent/JP4668265B2/ja not_active Expired - Fee Related
- 2005-05-18 US US11/132,019 patent/US7368446B2/en not_active Expired - Lifetime
- 2005-05-20 DO DO2005000091A patent/DOP2005000091A/es unknown
- 2005-05-20 MY MYPI20052309A patent/MY140011A/en unknown
- 2005-05-20 TW TW094116495A patent/TWI358297B/zh not_active IP Right Cessation
- 2005-05-23 GT GT200500124A patent/GT200500124A/es unknown
- 2005-05-23 HN HN2005000238A patent/HN2005000238A/es unknown
- 2005-05-23 PA PA20058633901A patent/PA8633901A1/es unknown
- 2005-05-23 AR ARP050102104A patent/AR048973A1/es not_active Application Discontinuation
- 2005-05-23 PE PE2005000569A patent/PE20060274A1/es active IP Right Grant
- 2005-05-24 SV SV2005002125A patent/SV2006002125A/es unknown
2006
- 2006-10-24 CR CR8703A patent/CR8703A/es unknown
- 2006-11-02 ZA ZA200609136A patent/ZA200609136B/xx unknown
- 2006-11-14 TN TNP2006000371A patent/TNSN06371A1/fr unknown
- 2006-11-16 IL IL179364A patent/IL179364A/en active IP Right Grant
- 2006-11-21 EC EC2006007018A patent/ECSP067018A/es unknown
- 2006-11-22 MA MA29481A patent/MA28601B1/fr unknown
- 2006-12-12 NO NO20065732A patent/NO336939B1/no not_active IP Right Cessation
2008
- 2008-02-28 CY CY20081100232T patent/CY1108104T1/el unknown

Also Published As

Publication number	Publication date
CN1956983B (zh)	2010-05-26
BRPI0511543B1 (pt)	2022-05-10
EA011279B1 (ru)	2009-02-27
ECSP067018A (es)	2006-12-29
TWI358297B (en)	2012-02-21
ATE382619T1 (de)	2008-01-15
CN1956983A (zh)	2007-05-02
HRP20080027T3 (hr)	2008-05-31
HN2005000238A (es)	2008-07-14
BRPI0511543A (pt)	2008-01-02
IL179364A (en)	2013-01-31
DE602005004142D1 (de)	2008-02-14
SV2006002125A (es)	2006-02-15
ES2297710T3 (es)	2008-05-01
CA2567703C (en)	2013-03-05
DK1753760T3 (da)	2008-04-14
AR048973A1 (es)	2006-06-14
MXPA06013417A (es)	2007-01-23
PE20060274A1 (es)	2006-04-14
NO20065732L (no)	2006-12-22
NO336939B1 (no)	2015-11-30
JP4668265B2 (ja)	2011-04-13
UA87142C2 (xx)	2009-06-25
JP2008500295A (ja)	2008-01-10
US7368446B2 (en)	2008-05-06
IL179364A0 (en)	2007-03-08
MY140011A (en)	2009-11-30
MA28601B1 (fr)	2007-05-02
DE602005004142T2 (de)	2009-01-02
TW200612937A (en)	2006-05-01
PL1753760T3 (pl)	2008-06-30
EP1753760A1 (en)	2007-02-21
NZ550763A (en)	2010-07-30
GT200500124A (es)	2005-12-26
TNSN06371A1 (fr)	2008-02-22
SI1753760T1 (sl)	2008-04-30
EP1753760B1 (en)	2008-01-02
RS50574B (sr)	2010-05-07
AU2005247567B2 (en)	2010-09-02
CA2567703A1 (en)	2005-12-08
WO2005116026A1 (en)	2005-12-08
AU2005247567A1 (en)	2005-12-08
US20050261289A1 (en)	2005-11-24
DOP2005000091A (es)	2005-06-29
PA8633901A1 (es)	2006-05-16
EA200602048A1 (ru)	2007-06-29
CR8703A (es)	2007-10-04
HK1105199A1 (en)	2008-02-06
CY1108104T1 (el)	2014-02-12
PT1753760E (pt)	2008-02-12

Publication	Publication Date	Title
IL178884A0 (en)	2007-03-08	Novel cis-imidazolines
IL179730A0 (en)	2007-05-15	Novel cis-imidazolines
IL179364A0 (en)	2007-03-08	4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
TWI372750B (en)	2012-09-21	Novel hydroxy-6-heteroarylphenanthridines
ZA200704636B (en)	2008-09-25	2-alkyl-cycloalk(en)yl-carboxamides
GB0414026D0 (en)	2004-07-28	Novel uses
ZA200804845B (en)	2009-05-27	Bubbling brick
ZA200610303B (en)	2010-05-26	Novel cis-imidazolines
GB0408865D0 (en)	2004-05-26	Novel benzoxazocines
ZA200606635B (en)	2008-05-28	Novel isoamido-substituted hydroxy-6-phenylphenanthridines
GB0400329D0 (en)	2004-02-11	Novel processes
GB0400382D0 (en)	2004-02-11	Novel processes
GB0420607D0 (en)	2004-10-20	Amino acid
GB0425900D0 (en)	2004-12-29	Novel pyrrolopyridine-2-carboxylic acid amide
GB0416455D0 (en)	2004-08-25	Lo-ro (lotion-roller)
GB0408864D0 (en)	2004-05-26	Novel benzoxazocines
GB0408863D0 (en)	2004-05-26	Novel benzoxazocines
GB0408862D0 (en)	2004-05-26	Novel benzoxazocines
ZA200608482B (en)	2008-04-30	Novel tetrahydropyridothiophenes
AU156233S (en)	2004-08-20	Clear can
GB0400405D0 (en)	2004-02-11	Novel processes
GB0412872D0 (en)	2004-07-14	Novel structures
GB0408300D0 (en)	2004-05-19	Novel inhibitors
GB0424820D0 (en)	2004-12-15	Novel uses
GB0420312D0 (en)	2004-10-13	Novel uses